Shandong Pharmaceutical Glass Co Ltd
SSE:600529
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
CN |
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
17.2B CNY | 13.6 | |
CH |
Alcon AG
SIX:ALC
|
40.6B CHF | 29.8 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 30.4 | ||
DK |
Coloplast A/S
CSE:COLO B
|
189B DKK | 91.3 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19.2B USD | 23.3 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 38.9 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58B CNY | 36.4 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 342.9 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.4B CHF | 34.1 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.7B USD | 17 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.8T KRW | -60.9 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.